These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7286003)

  • 1. Peyronie's disease: experience of local treatment with Orgotein.
    Gustafson H; Johansson B; Edsmyr F
    Eur Urol; 1981; 7(6):346-8. PubMed ID: 7286003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orgotein in the treatment of plastic induration of the penis (Peyronie's disease).
    Primus G
    Int Urol Nephrol; 1993; 25(2):169-72. PubMed ID: 8365848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orgotein, a new drug for the treatment of Peyronie's disease.
    Bartsch G; Menander-Huber KB; Huber W; Marberger H
    Eur J Rheumatol Inflamm; 1981; 4(2):250-9. PubMed ID: 7044791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The conservative treatment of Peyronie's disease with orgotein].
    Ianev V; Tsvetkov D
    Khirurgiia (Sofiia); 1989; 42(6):57-9. PubMed ID: 2634802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis).
    Ludwig G
    Urol Int; 1991; 47(4):236-9. PubMed ID: 1781108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Orgotein and La Peyronie's disease].
    Boccafoschi C; Montefiore F
    Minerva Urol Nefrol; 1987; 39(2):125-8. PubMed ID: 3629408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Orgotein iontophoresis in the therapy of induratio penis plastica].
    Schieroni MP; Revello MP; Colombo M; Randone DF; Rolle L
    Minerva Med; 1985 May; 76(22-23):1085-8. PubMed ID: 3892367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [La Peyronie's disease. Our experience].
    Revelli G; Marino B; Piccoli F; Vitale L; Kiss A; Rossi R; Lanfranchi M; Drago GW
    Minerva Chir; 1990 Jan; 45(1-2):47-50. PubMed ID: 2186297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.
    Montorsi F; Salonia A; Guazzoni G; Barbieri L; Colombo R; Brausi M; Scattoni V; Rigatti P; Pizzini G
    J Androl; 2000; 21(1):85-90. PubMed ID: 10670523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induratio penis plastica. Therapy with orgotein].
    Bickeböller R; Balducci M; Jonas D
    Fortschr Med; 1988 Sep; 106(27):558-60. PubMed ID: 3181851
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity reaction after orgotein (superoxide dismutase) administration.
    Corominas M; Bas J; Romeu A; Valls A; Massip E; González L; Mestre M; Buendía E
    Allergol Immunopathol (Madr); 1990; 18(5):297-9. PubMed ID: 2151501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of induratio penis plastica with intralesional infiltration of orgotein. Our experience in 5 cases].
    Rossi A; Turco P; Vozza A
    G Ital Dermatol Venereol; 1987 Dec; 122(12):675-7. PubMed ID: 3329150
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of Peyronie's disease.
    Hellstrom WJ
    J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
    Abdel Raheem A; Capece M; Kalejaiye O; Abdel-Raheem T; Falcone M; Johnson M; Ralph OG; Garaffa G; Christopher AN; Ralph DJ
    BJU Int; 2017 Nov; 120(5):717-723. PubMed ID: 28612401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peyronie disease: observations on 40 cases treated with orgotein].
    Calabro A; Pegoraro V; Aragona F; Tasca A; Artibani W; Lembo A
    Arch Esp Urol; 1985; 38(6):529-32. PubMed ID: 3833060
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iontophoresis in Peyronie's disease. Our experience].
    Pérez Espejo Mde L; Campoy Martínez P; Pérez Pérez M; Argüelles Salido E; Rodríguez Pérez A; Soltero González A
    Arch Esp Urol; 2003 Dec; 56(10):1133-7. PubMed ID: 14763419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.